| 產(chǎn)品編號 | 圖片 | CAS No. | 名稱及描述 | 規(guī)格 | 價(jià)格 | 分子式 | 快速訂購 |
|---|---|---|---|---|---|---|---|
| GC34215-5mg |
|
180288-69-1 |
Trastuzumab (Anti-Human HER2, Humanized Antibody) - Glpbio |
0 | 需詢價(jià) | C6470H10012N1726O2013S42 | |
| GC34215-1mg |
|
180288-69-1 |
Trastuzumab (Anti-Human HER2, Humanized Antibody) - Glpbio |
0 | 需詢價(jià) | C6470H10012N1726O2013S42 | |
| GC34214-5mg |
|
331731-18-1 |
Adalimumab (Anti-Human TNF-alpha, Human Antibody) - Glpbio |
0 | 需詢價(jià) | — | |
| GC34214-1mg |
|
331731-18-1 |
Adalimumab (Anti-Human TNF-alpha, Human Antibody) - Glpbio |
0 | 需詢價(jià) | — | |
| GC34213-5mg |
|
815610-63-0 |
Ustekinumab (Anti-Human IL-12/IL-23, Human Antibody) - Glpbio |
0 | 需詢價(jià) | — | |
| GC34213-1mg |
|
815610-63-0 |
Ustekinumab (Anti-Human IL-12/IL-23, Human Antibody) - Glpbio |
0 | 需詢價(jià) | — | |
| GC34212-5mg |
|
— |
Obinutuzumab (GA101) - Glpbio |
0 | 需詢價(jià) | — | |
| GC34212-1mg |
|
— |
Obinutuzumab (GA101) - Glpbio |
0 | 需詢價(jià) | — | |
| GC34211-5mg |
|
943609-66-3 |
Vedolizumab (Anti-Human lymphocyte α4β7 integrin, Humanized Antibody) - Glpbio |
0 | 需詢價(jià) | — | |
| GC34211-50mg |
|
943609-66-3 |
Vedolizumab (Anti-Human lymphocyte α4β7 integrin, Humanized Antibody) - Glpbio |
0 | 需詢價(jià) | — | |
| GC34211-25mg |
|
943609-66-3 |
Vedolizumab (Anti-Human lymphocyte α4β7 integrin, Humanized Antibody) - Glpbio |
0 | 需詢價(jià) | — | |
| GC34211-1mg |
|
943609-66-3 |
Vedolizumab (Anti-Human lymphocyte α4β7 integrin, Humanized Antibody) - Glpbio |
0 | 需詢價(jià) | — | |
| GC34210-5mg |
|
— |
Pertuzumab (Anti-Human HER2, Humanized Antibody) - Glpbio |
0 | 需詢價(jià) | — | |
| GC34210-1mg |
|
— |
Pertuzumab (Anti-Human HER2, Humanized Antibody) - Glpbio |
0 | 需詢價(jià) | — | |
| GC34209-25mg |
|
174722-31-7 |
Rituximab (Anti-Human CD20 type I, Chimeric Antibody) - Glpbio |
0 | 需詢價(jià) | C6416H9874N1688O1987S44 | |
| GC34209-5mg |
|
174722-31-7 |
Rituximab (Anti-Human CD20 type I, Chimeric Antibody) - Glpbio |
0 | 需詢價(jià) | C6416H9874N1688O1987S44 | |
| GC34209-1mg |
|
174722-31-7 |
Rituximab (Anti-Human CD20 type I, Chimeric Antibody) - Glpbio |
0 | 需詢價(jià) | C6416H9874N1688O1987S44 | |
| GC34208-25mg |
|
— |
GNE 220 Hydrochloride - Glpbio |
0 | 需詢價(jià) | C25H27ClN8 | |
| GC34208-10mg |
|
— |
GNE 220 Hydrochloride - Glpbio |
0 | 需詢價(jià) | C25H27ClN8 | |
| GC34208-5mg |
|
— |
GNE 220 Hydrochloride - Glpbio |
0 | 需詢價(jià) | C25H27ClN8 | |
小泰
|
010-60710855
|